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Background: In early stages of idiopathic Parkinson's disease (IPD), lower order vision (LOV) deﬁcits including re-
duced colour and contrast discrimination have been consistently reported. Data are less conclusive concerning
higher order vision (HOV) deﬁcits, especially for facial emotion recognition (FER). However, a link between
both visual levels has been hypothesized.
Objective: To screen for both levels of visual impairment in early IPD.
Methods:We prospectively recruited 28 IPD patients with disease duration of 1.4 +/− 0.8 years and 25 healthy
controls. LOV was evaluated by Farnsworth-Munsell 100 Hue Test, Vis-Tech and Pelli-Robson test. HOV was ex-
amined by the Ekman 60 Faces Test and part A of the Visual Object and Space recognition test.
Results: IPD patients performed worse than controls on almost all LOV tests. The most prominent difference was
seen for contrast perception at the lowest spatial frequency (p = 0.0002). Concerning FER IPD patients showed
reduced recognition of “sadness” (p = 0.01). “Fear” perception was correlated with perception of low contrast
sensitivity in IPD patients within the lowest performance quartile. Controls showed a much stronger link be-
tween “fear” perception” and low contrast detection.
Conclusion: At the early IPD stage there are marked deﬁcits of LOV performances, while HOV performances are
still intact, with the exception of reduced recognition of “sadness”. At this stage, IPD patients seem still to com-
pensate the deﬁcient input of low contrast sensitivity, known to be pivotal for appreciation of negative facial
emotions and conﬁrmed as such for healthy controls in this study.© 2014 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Processing visual information occurs at two levels. The lower order
vision (LOV) is involved in colour identiﬁcation, contrast sensitivity
and processing of line orientation. Higher order vision (HOV) is respon-
sible for further processing visual input, leading to object recognition,
space andmotion perception, face identiﬁcation, and facial emotion rec-
ognition (FER). During the early motor stage of idiopathic Parkinson's
disease (IPD), patients regularly showLOVdeﬁcits. Standardized clinical
tests supported by computer-driven evaluation, optical coherence to-
mography and neuroimaging techniques have convincingly shown
that colour discrimination and contrast sensitivity are impaired [1–3].Luxembourg, Department of
bourg. Tel.: +352 44 11 6627;
V. Open access under CC BY-NC-ND licIn terms of HOV, studies yield less conclusive results. IPD patients
show impairment for space perception and object recognition [4]. How-
ever, most of the studies have been performed at an advanced stage of
the disease. Controversy has also arisen concerning the recognition of
facial expressions. While it is generally accepted that IPD patients may
be most susceptible to misperception of negative emotions [5–7], the
causes of these deﬁcits remain controversial. Potential contributing fac-
tors have been proposed such as male gender, predominant right-
hemisphere pathology, executive dysfunction, apathy, dopaminergic
therapy or its withdrawal and deep brain stimulation of the nucleus
subthalamicus [7–9]. At an early disease stage – the focus of interest of
the present study – some authors have reported marked impairment
[5], others only mild restrictions [10], or no deﬁcit at all [11]. Evidently,
other visuo-spatial deﬁcits may play a substantial role as well, but have
not been analysed as such. A potential important link is suggested by
ﬁndings physiologically linking intact perception of low contrast to
rapid recognition of negative emotional face expressions [12].
Based on these ﬁndings we designed the present study and hypoth-
esized that, at an early motor stage of IPD, patients may show impaired
LOV, but would produce only mild deﬁcits of HOV, especially in the do-
main of FER. So far no study has systematically investigated such poten-
tial links between LOV and FER at an early IPD stage.ense.
179G. Hipp et al. / Journal of the Neurological Sciences 338 (2014) 178–1822. Methods and materials
2.1. Subjects
Within an ongoing study on the evolution of non motor signs in
early IPD [13], we recruited 28 patients at a very early stage of the dis-
ease. Thus all patients had to satisfy to the strict inclusion criterion of
equal or less than three years of disease duration. The diagnosis was
established according to the UK Parkinson's Disease Society Brain
Bank clinical diagnostic criteria [14]. Twenty-ﬁve healthy control sub-
jects were recruited, mainly as spouses of IPD patients or by the mass
media. Visual acuity was tested in all subjects, while wearing their
best glasses and at a ﬁve meter distance from the board. All had normal
visual acuity as assessed by a Snellen fraction N0.6. In a standardized
way all subjects were proactively and systematically asked about visual
hallucinations and illusions. IPD patients were tested on their usual do-
paminergic medication. All subjects gave informed written consent be-
fore entering the study. The study was approved by the National Ethical
Research Committee of Luxembourg (CNER).
2.2. Methods
2.2.1. LOV evaluation
Contrast sensitivity was tested by two wall-mounted charts: Vis-
tech test and Pelli Robson test. Colour discrimination was assessed by
the Farnsworth-Munsell 100 Hue test.
In the Vis-tech test [15] chart photographs of sinusoidal gratings are
presented and thresholds for different spatial frequencies are deter-
mined by the subject recognising the correct orientation of the stripes
of the gratings varying in contrast. Subjects are placed at three meters
from the chart. The test is performed in normal daylight conditions.
For each of the ﬁve different spatial frequencies (1.5 cycles per degree
(cpd), 3 cpd, 6 cpd, 12 cpd, 18 cpd), nine ﬁgures with decreasing con-
trasts are presented. Subjects have to determine the line orientation
(to the left, right, up, down). The scores for each spatial frequency are
the sum of correctly identiﬁed items (1–9). In the Pelli-Robson test
[16] standard sized letters of uniform spatial frequency are presented
with decreasing contrast on a chart, as the subjects read along a line,
allowing threshold detection. There are two triplets of letters per line,
the contrast being decreased for each triplet. This chart is placed at
one meter from the subjects and performed in normal daylight condi-
tions. In the Farnsworth-Munsell 100 Hue test [17], subjects have to
place caps of different shades of colours in the right order. The test is
performed under daylight conditions by using a special daylight lamp
(Richmont Flat Tray True-Daylight Illuminator). The caps are arranged
in four boxes, each containing a ﬁxed anchor cap at each end. There
are 4 colour axes: yellow, blue, green and red. For each colour axis an
error score is calculated, following the manufacturer's recommenda-
tions and as similarly applied in other studies [13].
2.3. FER evaluation
FER was evaluated with the Ekman 60 Faces Test (E60FT). This test
explores six emotions: anger, fear, disgust, happiness, sadness, and sur-
prise [18]. Subjects are placed in front of a computer screen where they
are shown ,one by one, 60 greyscale photographs of faces expressing
one of the six emotions. Subjects have to indicate which one of the six
possible emotions is expressed. For each emotion, there are ten portraits
expressing this emotion, so the possible score for each emotion ranges
between 0 and 10.
2.4. Visual object perception (VOP)
Visual object perceptionwas evaluated by part A of the Visual Object
and Space Perception (VOSP) battery [19]. There are four subtests. In the
subtest “incomplete letters” twenty letters that are partially degradedhave to be identiﬁed. In the subtest “silhouettes” the participant has to
identify 15 animal silhouettes and 15 inanimate object silhouettes, all
presented in an unusual perspective. In the subtest “object decision”
four objects are presented in a rotated manner; three are not real ob-
jects; the subject has to identify the one real object out of the four. Final-
ly, in the subtest “progressive silhouettes”, the subject has to identify a
gun and a trumpet; both objects are presented as ten silhouettes that
are initially abstract and progressively revealing more details.
2.5. Executive functions and sequencing of the tests
Executive functions were evaluated by the Frontal Assessment Bat-
tery (FAB) and motor sequencing by the Trail Making Test A (TMT A).
The tests were administered by two experienced neuropsychologists
(GH and VP) on two different days. FER and VOP were tested during
the ﬁrst session, FAB, TMTA and LOV during the second session. Impor-
tantly, in order to avoid reduction of the attention span, pauses were
regularly inserted in the testing program.
2.6. Data analysis
The means between the two groups were compared by using
ANOVA on raw values and by using the Mann–Whitney test. The inter-
dependency between the test results within groups was analysed with
Pearson correlation coefﬁcients. We deﬁned the values derived from
the tests Farnworth-Munsell, Vis-tech and Pelli-Robson as primary out-
come variables. For multiple comparisons we used the Hochberg com-
parison (1988) to correct the individual p values (proc multitest in
SAS version 9.3).
3. Results
3.1. Descriptive demographics
Gender distribution was similar in both groups. IPD group: 15
women and 13 men; control group: 15 women and 10 men (NS). Age
was similar in both groups: 62.49 +/− 11.9 years in the IPD group ver-
sus 59.57 +/− 7.4 years in the control group (p = 0.09). In IPD pa-
tients disease duration was 1.36 +/− 0.8 years and the score on the
motor part of the Uniﬁed Parkinson Disease Rating Scale (UPDRS),
while being “on” medication, was 8.39 +/− 3.52 [range: 0–25]. The
mean daily levodopa dosage in the IPD patients was 198.4 ± 248.3 mg.
3.2. Cognitive performances
No subject had a pathological score on the MMSE and the mean
values were: 28.8 ± 1.4 [range: 25–30] for the IPD patients and
29.4 ± 0.7 [range: 28–30] for the controls (p = 0.03). No subject
scored N0 at the Clinical Dementia Rating Scale (CDRS). No participant
reported visual hallucinations. IPD patients had lower performances
than controls on the FAB (15.46 +/− 1.57 vs. 17.08 +/− 0.95,
p b 0.00001). They also performed more slowly on the TMT A test
than the controls (42.8 ± 13.9 vs. 36.0 ± 10.8, p = 0.04).
3.3. LOV performances
3.3.1. Colour discrimination and contrast sensitivity (Table 1)
The IPD patients performed worse than control subjects on all the
LOV tests. Concerning colour discrimination, there was a signiﬁcant dif-
ference for one of the four colour axes (red: p = 0.03). The total error
score was higher in IPD patients than in control subjects, but not signif-
icantly, due to high variability. Concerning contrast sensitivity evaluated
by Vistech, the highest difference concerned the lowest spatial frequen-
cy (1.5 cycles/degree: p = 0.0002). The IPD patients performed
worse than control subjects on the Pelli-Robson test for binocular
(p = 0.0002) vision only. All results are listed in Table 1 which, of
Table 1
Mean scores of 28 IPD patients and 25 control subjects in terms of colour discrimination,
contrast sensitivity and performances in the visual object and space recognition.
(Hochberg correction for multiplicity of comparisons has been applied).
IPD (N = 28) Controls (N = 25) P value
Colour discrimination (raw values)
FM yellow axis 14.7 ± 13.9 8.3 ± 13.4 0.21§
FM green axis 27.8 ± 17.0 20 ± 16.6 0.23§
FM blue axis 38.7 ± 36.9 21.2 ± 17.5 0.16§
FM red axis 27.3 ± 16.8 13.8 ± 15.05 0.03§
FM total score 108.4 ± 71.8 63.3 ± 55.9 0.05§
Contrast discrimination (raw values)
VT 1.5 cpd 5.3 ± 0.8 6.4 ± 0.6 0.0002
VT 3 cpd 5.7 ± 0.9 6.3 ± 0.6 0.08*
VT 6 cpd 4.9 ± 1.0 5.5 ± 1.0 0.34
VT 12 cpd 3.8 ± 1.2 4.4 ± 1.0 0.37
VT 18 cpd 2.9 ± 1.4 3.7 ± 1.5 0.34
PR left eye 1.4 ± 0.2 1.6 ± 0.2 0.18
PR right eye 1.3 ± 0.2 1.5 ± 0.2 0.18
PR binocular 1.5 ± 0.2 1.6 ± 0.1 0.0002
Visual object and space recognition (raw values)
Gradients 11.8 ± 2.8 11.0 ± 2.9 0.75
Incomplete letters 19.4 ± 1.0 19.5 ± 0.6 0.75
Recognition 13.4 ± 3.6 14.6 ± 1.7 0.54*
Screen 19.8 ± 0.5 19.8 ± 0.4 0.75
Silhouettes 16.5 ± 4.6 19.5 ± 4.8 0.24&
FM: Farnsworth Munsell 100 Hue Test; VT: Vis-tech; cpd: cycles per degree.
PR: Pelli Robson IPD: Idiopathic Parkinson's disease.
§ ANOVA (log-transformed values) * = Welch Anova; & = Mann–Whitney test.
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3.4. HOV performances
3.4.1. Recognition of facial emotion and visual objects
In terms of object and space recognition, IPD patients and controls
performed similarly (Table 1). Concerning FER, IPD patients performed
worse than control subjects for the emotion “sadness” (IPD: 6.5 ± 2.3,
controls: 8.0 ± 1.8; p = 0.01). There were no further signiﬁcant differ-
ences between both groups (Fig. 1). However it should be noted that
IPD patients performed better on recognition of positive emotions and
control subjects better on recognition of negative emotions.
3.4.2. Are HOV performances linked to LOV performances?
In the IPD group, we found no overall correlation between LOV and
FER performances. However, the quartile of IPD patientswith the lowest*= p= 0.01
0
2
4
6
8
10
12
Anger Disgust Fear Happy Sadness Surprise
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PARKINSON
*
Fig. 1.Mean scores in facial emotion recognition, as tested by the Ekman 60 Faces Test in
28 IPD patients and 25 control subjects. * = p = 0.01.performances for “fear” recognition performed also worse than other
IPD patients in the Vistech 12-test (p = 0.04) and the Pelli-Robson-
left test (p = 0.03). In contrast, in healthy controls perception of con-
trast sensitivity and colour discrimination was in general linked with
the recognition of the negative emotion “fear” (Table 2). Such a link
was not seen for other emotions, neither in control subjects nor in IPD
patients (results not shown).3.4.3. Potential confounders
In the IPD group, no correlation was found between age and LOV re-
spectively FER, except for the recognition of surprise, which was linked
to age (r = −0.4, p = 0.03). The levodopa medication was not corre-
lated to LOV or FER. The gender of the IPD subjects had only an inﬂuence
on fear recognition (males: 6.6 +/− 2.2, females: 4.4 +/− 2.8;
p = 0.05), while all other FER and LOV performances were similar. Ex-
ecutive dysfunction represented by lower score on the FAB was only
correlated with the recognition of anger (r = 0.5; p = 0.01). This link
was maintained after Hochberg correction for test multiplicity. There
was no inﬂuence of processing speed, expressed as TMT A score, on
any outcome variable (results not shown).4. Discussion
This study conﬁrms marked deﬁcits of colour discrimination and
contrast sensitivity in IPD patients at a very early disease stage, with sig-
niﬁcant differences concerning the discrimination of colours within the
red spectrum and the contrast sensitivity of sinusoidal gratings present-
ed at the lowest spatial frequency. In contrast, most performances of
high order vision are still intact. This applies in particular to the percep-
tion of facial emotion expression, with preserved recognition of all pos-
itive and most negative facial expressions, including disgust. Only
perception of sadness is impaired. Furthermore IPD patients with the
lowest performances concerning “fear” detection (lowest quartile)
have also the lowest scores on contrast sensitivity. In contrast, but as
predicted by literature [12], healthy controls evidenced a general and
robust link between perception of “fear” and performances in several
HOV domains. Thus, our results conﬁrm, to some extent, that a link be-
tween LOV and “fear” recognition exists in normal subjects, but this link
is much looser in IPD patients. This discrepancy suggests that compen-
satory mechanisms are functional in IPD patients or that facial emotion
processing is processed differently in IPD patients than in normal sub-
jects. Before explicitly discussing these issues, it is worthwhile to, ﬁrst,
recapitulate the anatomical pathways involved in emotional face recog-
nition and, second, to present in more detail the concept linking low
contrast discrimination with emotional face recognition.Table 2
Correlations betweendifferent LOVperformances and “fear” recognition in 28 IPDpatients
and in 25 control subjects.
IPD Controls
r P value r P value
FM total −0.005 ns −0.5 0.006
FM yellow −0.2 ns −0.5 0.005
FM green 0.02 ns −0.3 ns
FM blue −0.006 ns −0.5 0.01
FM red 0.1 ns −0.5 0.006
PR bino −0.004 ns 0.4 0.03
VT 1.5 cpd −0.2 ns −0.04 ns
VT 3 cpd −0.1 ns −0.02 ns
VT 6 cpd −0.006 ns 0.2 ns
VT 12 cpd 0.1 ns 0.4 0.04
VT 18 cpd 0.2 ns 0.5 0.02
FM = Farnsworth Munsell 100 Hue; PR bino = Pelli Robson binocular vision.
VT = Vis-tech; cpd = cycles per division; r = Pearson correlation coefﬁcient.
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Lesion and neuroimaging studies have proposed that FER is mediat-
ed by pathways projecting to the inferior frontal area within the
prefrontal cortex and to the temporo-parietal cortex [20,21]. The amyg-
dala, especially on the right side, is a pivotal relay station within the cir-
cuitry and functions as emotion regulation system [22,23]. Of note,
recognition of disgust also involves the basal ganglia [20]. This implica-
tion of basal ganglia and amygdala in FER suggests that IPD patientsmay
be impaired in emotion recognition, at least in stage 3 according to
Braak, which is the earliest motor stage of the disease and explored as
such in the present study.
4.2. Linking low contrast sensitivity and facial emotion recognition
At ﬁrst look it is difﬁcult to explain why LOV performances should –
also – be linked with facial emotion recognition. In short, low contrast
sensitivity contributes to the “rapid glimpse” appreciation of negative
emotions. Thismeans that in normal adults the perception of the facially
expressed emotions ismediated, in a ﬁrst step, by the subcortical retino–
colliculo–pulvinar–amygdala (RCPA) pathway [24]. This magnocellular
pathway uses lower spatial frequencies for rapidly exploring the face
expression. It avoids the slower visual pathway via the cortical area
V1, which later induces a conscious emotion identiﬁcation using high
spatial frequencies [12,25]. The RCPA is fully developed in the newborn
[26]. It is thought to be a phylogenetically ancient pathway, “critical for
survival”, by allowing “expedient detection of fear-related cues through
covert circuitries, in which the amygdala plays an essential role” [12].
Is there a paradox between both concepts of FER, one linking FER
with distinct anatomical brain regions, the other linking it with “basic”
visual performances? Indeed, at ﬁrst look, both pathways seem not to
overlap. However FER can be subdivided into two processes:
(a) subconscious “identiﬁcation” which can be categorized within
the performances of the LOV rather than those of the HOV by
its physiological properties;
(b) conscious recognition of the emotion mediated by cortical brain
structures and to be classiﬁed as HOV performance only.
Intact subcortical emotion processing facilitates the explicit emotion
recognition by feedback processes between both, cortical and subcorti-
cal, pathways. It is, however, not an obligatory precondition [27].
4.3. Why distinct deﬁcits in IPD?
The just proposed dissection of FER into two distinct processes ex-
plains the seemingly dichotomy of the performances in early IPD pa-
tients. While healthy controls fully take advantage of the low contrast
input when identifying a negative face expression, IPD patients mostly
compensate for the deﬁcient input of contrast detection. How could
such compensatory mechanism function? Possibly, visual scanning of
the face is used more extensively, and sustained ﬁxations of the upper
facial parts compensate the missing immediate appreciation [7]. A
clue for such compensatorymechanisms atwork is that in asymptomat-
ic Parkin carriers functional MRI has evidenced increased activity in
premotor areas acting as mirror neurons in those patients maintaining
best performances in FER [28]. Furthermore, both pathways target the
amygdala as “terminus”, respectively as relay station. In IPD, cellular
loss and high burden of Lewy bodies have been shown in particular in
the amygdalar subnucleus called the cortical amygdaloid nucleus [29].
“Silent amygdala” or amygdala dysfunction has been proposed in IPD
to be involved in odour misidentiﬁcation, autonomic disturbances, and
visual hallucinations. Reduced FER in IPD patients is thus a plausible
ﬁnding. However, this reduction remains modest, sustaining the hy-
pothesis that amygdala dysfunction in patients with IPD only modiﬁes
the neural pathways implicated in facial emotion recognition [27]. Fi-
nally, the fact that a link between LOV and HOV only appears in IPDpatients most impaired in “fear” recognition, suggests, that only in
these latter patients, compensatory strategies become insufﬁcient, the
reasons for this insufﬁciency being unknown.
4.4. Limitations of the study
Our study has several limitations. The LOV testsmay be biased by re-
duced sustained attention, although we tried to control this variable by
inserting pauses, other tests and questionnaires. IPD patients were test-
ed, while being “on” their usual medication. It has been shown, that in
non medicated patients colour discrimination and emotional face per-
ception may be worse than in medicated patients [5]. We found no
link between dopaminergic medication and visual performances. So,
at worst, HOV deﬁcits may be underestimated, but not overestimated
in our cohort. The cohort size is relatively small and age differences
may have inﬂuenced the results. In fact, it has been shown, that recog-
nition of the negative emotions anger, fear and sadness decreases with
age but not recognition of disgust, which seems to remain stable even
with advanced age [30]. Finally, we did not perform a sub-analysis, com-
paring IPD patients with right-dominant basal ganglia pathology to IPD
patients with left-dominant pathology.
5. Conclusions
This study directly compares for the ﬁrst time deﬁcits of lower order
and higher order vision in IPD patients at a very early stage of the dis-
ease. Both parts of the visual system are already involved, but to a sub-
stantially different extent. Most IPD patients seem to efﬁciently
compensate for LOVdeﬁcitswhen performing tests of HOV, in particular
when recognizing facial emotions. Due to the inherent pathology of IPD,
with both anatomical proof of amygdala involvement and psychophys-
iological proof of reduced low contrast perception, deterioration of fa-
cial emotion recognition seems, however, to be unavoidable on the
long-term, with insufﬁcient compensatory mechanisms in all patients,
and not only some. Follow-up studies of the present cohort will be
planned; conﬁrmation in larger cohorts, possibly including ocular pur-
suit evaluation, is warranted.
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